Free Trial

Blueprint Medicines (BPMC) Insider Trading & Ownership

$116.81
+1.84 (+1.60%)
(As of 07/22/2024 ET)

Blueprint Medicines (NASDAQ:BPMC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.21%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
11
Amount Of
Insider Selling
(Last 12 Months)
$28.55 M
Get BPMC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Blueprint Medicines stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BPMC Insider Buying and Selling by Quarter

Blueprint Medicines Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/5/2024Debra Durso-BumpusInsiderSell3,850$111.20$428,120.00  
7/3/2024Debra Durso-BumpusInsiderSell8,817$111.29$981,243.93  
6/28/2024Debra Durso-BumpusInsiderSell333$111.15$37,012.95  
6/21/2024Debra Durso-BumpusInsiderSell74,034$104.19$7,713,602.46  
6/5/2024Percy H CarterInsiderSell4,000$105.13$420,520.00  
6/3/2024L. Becker HewesInsiderSell4,922$106.43$523,848.46  
5/31/2024L. Becker HewesInsiderSell34,108$105.91$3,612,378.28  
5/2/2024Ariel HurleyInsiderSell1,834$103.88$190,515.92  
5/2/2024Michael LandsittelCFOSell10,000$105.00$1,050,000.00  
3/28/2024Michael LandsittelCFOSell5,000$95.00$475,000.00  
3/20/2024Jeffrey W AlbersDirectorSell25,073$87.28$2,188,371.44  
3/15/2024Michael LandsittelCFOSell13,734$87.78$1,205,570.52  
3/7/2024Christina RossiCOOSell6,070$90.69$550,488.30  
3/7/2024Jeffrey W AlbersDirectorSell11,033$90.69$1,000,582.77  
3/7/2024Kate HavilandCEOSell12,464$90.69$1,130,360.16  
3/7/2024L. Becker HewesInsiderSell3,097$90.69$280,866.93  
3/7/2024Michael LandsittelCFOSell5,003$90.69$453,722.07  
3/7/2024Tracey L MccainEVPSell5,194$90.69$471,043.86  
3/4/2024Christopher K MurrayInsiderSell621$93.65$58,156.65  
2/28/2024Christopher K MurrayInsiderSell5,000$100.00$500,000.00  
1/25/2024Jeffrey W AlbersDirectorSell25,000$81.91$2,047,750.00  
12/22/2023Ariel HurleyInsiderSell714$90.00$64,260.00  
12/7/2023Christopher K MurrayInsiderSell5,000$75.00$375,000.00  
12/4/2023Christopher K MurrayInsiderSell600$71.43$42,858.00  
11/30/2023Jeffrey W AlbersDirectorSell5,000$70.55$352,750.00  
11/24/2023Jeffrey W AlbersDirectorSell15,000$67.51$1,012,650.00  
11/3/2023Jeffrey W AlbersDirectorSell1,485$60.13$89,293.05  
11/1/2023Jeffrey W AlbersDirectorSell3,881$60.02$232,937.62  
10/26/2023Christopher K MurrayInsiderSell600$56.40$33,840.00  
10/4/2023Fouad NamouniInsiderSell3,769$48.06$181,138.14  
9/28/2023Jeffrey W AlbersDirectorSell6,898$50.17$346,072.66  
8/25/2023Jeffrey W AlbersDirectorSell10,000$50.16$501,600.00  
(Data available from 1/1/2013 forward)

BPMC Insider Trading Activity - Frequently Asked Questions

What percentage of Blueprint Medicines stock is owned by insiders?

4.21% of Blueprint Medicines stock is owned by insiders. Learn more on BPMC's insider holdings.

Which Blueprint Medicines insiders have been buying company stock?

The following insider purchased BPMC shares in the last 24 months: Kate Haviland ($48,378.00).

How much insider buying is happening at Blueprint Medicines?

Insiders have purchased a total of 1,100 BPMC shares in the last 24 months for a total of $48,378.00 bought.

Which Blueprint Medicines insiders have been selling company stock?

The following insiders have sold BPMC shares in the last 24 months: Ariel Hurley ($254,775.92), Christina Rossi ($714,305.75), Christopher K Murray ($1,246,604.65), Debra Durso-Bumpus ($9,535,529.34), Fouad Namouni ($415,140.24), Jeffrey W Albers ($11,994,527.05), Kate Haviland ($1,433,741.76), L. Becker Hewes ($4,417,093.67), Michael Landsittel ($3,321,652.35), Percy H Carter ($540,622.42), and Tracey L Mccain ($622,792.82).

How much insider selling is happening at Blueprint Medicines?

Insiders have sold a total of 413,647 Blueprint Medicines shares in the last 24 months for a total of $34,496,785.97 sold.


This page (NASDAQ:BPMC) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners